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Aims: There has been emerging interest in the prenatal determinants of respiratory disease. In utero factors
have been reported to play a role in airway development, inﬂammation, and remodeling. Speciﬁcally, prenatal
exposure to endotoxins might regulate tolerance to allergens later in life. The present study investigated
whether prenatal lipopolysaccharide (LPS) administration alters subsequent offspring allergen-induced
inﬂammatory response in adult rats.
Main methods: Pregnant Wistar rats were treated with LPS (100 μg/kg, i.p.) on gestation day 9.5 and their
ovariectomized female offspring were sensitized and challenged with OVA later in adulthood. The
bronchoalveolar lavage (BAL) ﬂuid, peripheral blood, bone marrow leukocytes and passive cutaneous
anaphylaxis were evaluated in these 75-day-old pups.
Key ﬁndings: OVA sensitized pups of NaCl treated rats showed an increase of leucocytes in BAL after OVA
challenge. This increase was attenuated, when mothers were exposed to a single LPS injection early in
pregnancy. Thus, LPS prenatal treatment resulted in (1) lower increased total and differential (macrophages,
neutrophils, eosinophils and lymphocytes) BAL cellularity count; (2) increased number of total, mononuclear
and polymorphonuclear cells in the peripheral blood; and (3) no differences in bone marrow cellularity or
passive cutaneous anaphylaxis.
Signiﬁcance: In conclusion, female pups treated prenatally with LPS presented an attenuated response to
experimentally-induced asthma. We observed reduced immune cell migration from peripheral blood to the
lungs, with no effect on the production of bone marrow cells or antibodies. It was suggested that
inﬂammatory events such as exposure to LPS in early fetal life can attenuate allergic inﬂammation in the lung,
which is a common symptom in asthma.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Asthma is an inﬂammatory lung disease characterized by cellular
recruitment, plasma exudation and airway hyper-responsiveness.
These hallmarks of asthma are induced by inﬂammatory mediators,
which are released from sensitized mast cells after antigen challenge
(Bryce et al., 2006; Busse and Lemanske, 2001).
The so-called ‘hygiene hypothesis’ or microbial deprivation
hypothesis suggests that a lack of exposure to microbial stimulation
early in childhood is a major factor involved in the increasing
prevalence of allergy and asthma (Conrad et al., 2009; Kalliomaki
et al., 2010). Although traditional postnatal ‘hygiene hypothesis’ riskSchool of Veterinary Medicine,
a, 87 São Paulo, SP 05508-000,
.
sevier OA license.factors play a clear role in the development of asthma and atopic
disease, there has been emerging interest in the prenatal determinants
of this respiratory disease (Kumar, 2008). There may be in utero and
early-life factors that play a role in airway development, inﬂammation,
and remodeling (Kumar, 2008). Speciﬁcally, it has been found that a
number of the epidemiological protective factors of the so-called
‘hygiene hypothesis’ are related to the effects of endotoxin and other
microbial exposure (Braun-Fahrlander et al., 2002; Gehring et al.,
2002) via innate immune system activation (Gern et al., 2004). For
example, in utero exposure to farming environments elicited protec-
tive effects on asthma phenotypes (Douwes et al., 2008). Furthermore,
it has been reported that prenatal exposure to immunological factors
may be evenmore important than early-life exposures (Douwes et al.,
2008; Kumar, 2008).
In fact, contact with lipopolysaccharide (LPS), a cell wall component
of Gram-negative bacteria, in early infancy is associated with decreased
allergen sensitization (Gerhold et al., 2002;Wang andMcCusker, 2006).
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and asthma have been performed in late pregnancy, or throughout
pregnancy (Blumer et al., 2005; Cao et al., 2010; Datti et al., 2008).
Thus, we believed that it would be relevant to study the effects of a
single early prenatal LPS exposure on gestation day (GD) 9.5 on
allergic lung inﬂammatory response in adult female rats. To this end,
ovariectomized female pups were then sensitized and challenged
with ovalbumin (OVA) in adulthood. The bronchoalveolar lavage
(BAL) ﬂuid, peripheral blood, bone marrow leukocytes and passive
cutaneous anaphylaxis were evaluated in these pups. GD 9.5 was
selected for LPS exposure since this date coincides with the beginning
of the pivotal pseudoglandular stage of prenatal lung development in
rats. This stage is most likely involved with the susceptibility to




Pregnant Wistar rats from our own colony, weighing 216–263 g
each, were used (GD 0 = spermatozoa in the vaginal smear). Dams
were individually housed in polypropylene cages (38×32×6 cm) at
controlled room temperature (22±2 °C), humidity (65–70%), and
artiﬁcial lighting (12-hour light/12-hour dark cycle, lights on at
6:00 a.m.) with free access to Nuvilab® rodent chow (Nuvital Co., São
Paulo, SP, Brazil) and ﬁltered water. Sterilized and residue-free wood
shavings were used as animal bedding. The dams were randomly
distributed into two control groups and one experimental group
(n=10/each group). These rats were allowed to give birth and
nurture their offspring normally. No cross-fostering procedure was
used. The day of birth was considered as postnatal day (PND) 1. No
handling was performed on PND 1, but on PND 2, 8 offspring (4 males
and 4 females) were randomly selected. Litters smaller than 8 pups
were culled. These eight pups were kept with each dam until weaning
(PND 21). On PND 21, the littermates were separated, housed
together by sex and grouped in the same laboratory conditions as
their parents. One female pup of each litter was used for the tests in
adulthood; the male offspring were separated, to be used in other
experiments (Kirsten et al., 2010b). All experiments were performed
between 7:00 and 12:00 am. The animals used in this study were kept
in accordance with the guidelines of the Committee on Care and Use
of Laboratory Animal Resources of the School of Veterinary Medicine,
University of São Paulo, Brazil (protocol No. 925/2006, FMVZ–USP).
These guidelines are similar to those of the National Institutes of
Health, Bethesda, MD. Experiments were carried out in accordance
with the GLP protocols and with quality assurance methods.
Treatment
LPS (from Escherichia coli, Sigma®, serotype 0127: B8) was
dissolved in sterile saline (50 μg/ml of LPS in 0.9% NaCl solution)
and was administered intraperitoneally (i.p.) to pregnant rats at a
dose of 100 μg/kg on GD 9.5. This dose was chosen because it has been
reported to (1) elicit sickness behavior in the dams, (2) induce
endocrine alterations, (3) increase cytokines at the placental level,
and (4) impair offspring viability and reduce the social behavior of
male offspring during infancy and adulthood (Kirsten et al., 2010b;
Spencer et al., 2007;Wang et al., 2006). The control group consisted of
pregnant rats submitted to the same treatment schedule, but with
sterile saline (0.9% NaCl). Each dam was treated with 0.1 ml/100 g
saline solution. An additional control group of ovariectomized female
rats were used as a negative control group, here called basal group.
These animals were not submitted to any treatment, i.e. prenatal and
OVA-sensitized and challenged in adulthood.Ovariectomy and validation of ovariectomy
Twenty female rat pups (1 from each litter, n=10/each group)
were ovariectomized on PND 53 to minimize the variables of the
experiment, since female sex hormones modify the course of allergic
pulmonary inﬂammation (Riffo-Vasquez et al., 2007). The ovariecto-
my and validation of ovariectomy were performed as described
elsewhere Ligeiro de Oliveira et al. (2004)). Brieﬂy, animals were
anesthetized with ketamine (100 mg/kg) and xylazine (20 mg/kg) by
i.p. injection. Upon laparotomy, the ovaries were surgically removed.
The effectiveness of ovariectomy was determined by analysis of the
vaginal smear and by quantiﬁcation of uterine weight. Only success-
fully ovariectomized females in the diestrus phase were used in the
experiments.
Rat model of allergic lung inﬂammation
The rat model of allergic lung inﬂammation was performed as
described elsewhere (Ligeiro de Oliveira et al., 2008). Brieﬂy, after
7 days of ovariectomy (PND 60), the female pupswere sensitizedwith
OVA (Egg Albumin Grade II, Sigma Chemical Company® USA). Seven
days later (PND 67), the animals were boosted with OVA, and seven
days later (PND 74), challenged with OVA aerosol.
Bronchoalveolar lavage (BAL) ﬂuid analysis
On PND 75, BAL was performed in female pups as previously
described by (Ligeiro de Oliveira et al., 2008). Brieﬂy, the animals
were anesthetized with ketamine plus xylazine, sacriﬁced, and their
lungs were ﬂushed for the total leukocyte and differential cell counts.
Peripheral blood analysis
Immediately before BAL collection, blood samples were taken from
the animal's abdominal aorta. The total number of cells and the
differential leukocyte counts were performed as described elsewhere
(Ligeiro de Oliveira et al., 2008).
Bone marrow analysis
The total number of bone marrow cells was quantiﬁed in the
femoral marrow lavage (FML) ﬂuid obtained as described elsewhere
(Ligeiro de Oliveira et al., 2008). Brieﬂy, after BAL and peripheral
blood collections, rat femurs were removed, the cells were collected
and analyzed for total leukocyte counts.
Passive cutaneous anaphylaxis
Passive cutaneous anaphylaxis (PCA) reactions were performed as
described elsewhere (Ligeiro de Oliveira et al., 2004). Brieﬂy, sera
from sensitized female pups were serially diluted and injected in the
shaved dorsal skin of unsensitized naive rats. After 24 h, these animals
received OVA and Evans blue in saline. Thirty minutes later, the rats
were killed, the skin was removed and the diameter of the dye stain on
the inner surface of the skin was measured. The PCA (IgE) titers
represent the highest dilution of the serum that gave a dye stainN5 mm
in diameter.
Statistical analysis
Results were expressed as mean±SEM. One female rat pup from
each dam was considered in the offspring studies to avoid litter
effects. Homoscedasticity was veriﬁed through the F test. Normality
was veriﬁed through the Kolmogorov–Smirnov test. Thus, parametric
data were analyzed by Student's t-test or by ANOVA, followed by the
17T.B. Kirsten et al. / Life Sciences 89 (2011) 15–19multiple comparisons Tukey–Kramer test. In all cases results were
considered signiﬁcant if pb0.05.
Results
Fig. 1 shows the effects of prenatal LPS exposure on total and
differential BAL cell count in OVA-sensitized and -challenged female rats.
This experiment was conducted to characterize OVA-induced allergic
inﬂammation in rats treated with prenatal LPS or vehicle. The total
number of cells (Panel A) in the BAL of control animals challenged with
OVAwas higher than that of the basal group (pb0.001); rat pups treated
prenatallywith LPS and challengedwithOVAdid showa smaller increase
in the number of cells in BAL after OVA challenge, compared to control/
OVAgroup (pb0.001); however, the total number of cells in the LPS/OVA
group remained higher than that observed in the basal group (pb0.001).
The number of macrophages (Panel B) of the control/OVA group was
higher than those of the basal group (pb0.001); a signiﬁcant reduction
was observed in the LPS/OVA group in relation to the control/OVA group


































































Fig. 1. Effects of prenatal LPS exposure (100 μg/kg on GD 9.5) on BAL (A) total cells (B) mac
challenged female rats. Basal group: naïve animals that remained undisturbed, with no treatm
PND 60; LPS/OVA: rats prenatally exposed to LPS and OVA-sensitized on PND 60. All measur
n=10 for both groups. Different superscript letters mean statistically signiﬁcant differences
and **** pb0.0001 (ANOVA and Tukey–Kramer tests).number of neutrophils (Panel C) in the control/OVA groupwas increased
in comparison to the basal group (pb0.001); the LPS/OVA group
presented a decrease in these cell types in relation to the control/OVA
group (pb0.001) but not in relation to the basal group (pN0.05). The
number of lymphocytes (Panel D) was increased in control/OVA group
data as compared to those of the basal group (pb0.01); a signiﬁcant
decrease in the number of these cellswas observed in the LPS/OVAgroup
when compared to the control/OVA group (pb0.05); no difference was
found between LPS/OVA group and the basal group (pN0.05). Panel E
represents the number of eosinophils. Because the basal data were null,
the unpaired t-test with Welch correction was applied to compare the
data of control/OVA and LPS/OVA groups. Thus, the LPS/OVA group
presented a signiﬁcant decrease in the number of eosinophils, compared
to the control/OVA group (pb0.0001).
Because the number of cells in the lungs resulting from bronchopro-
vocation was lowered increased by prenatal treatment with LPS, we
quantiﬁed (1) total number of, (2) mononuclear and (3) polymorpho-
nuclear cells present in the peripheral blood of prenatally treated and












































rophages, (C) neutrophils, (D) lymphocytes and (E) eosinophils of OVA-sensitized and
ent; Control/OVA: rats prenatally exposed to 0.9% NaCl solution and OVA-sensitized on
es were performed 12 h after the OVA challenge. Values are presented as mean±SEM.










































































Fig. 2. Effects of prenatal LPS exposure (100 μg/kg on GD 9.5) on (A) total number,
(B) mononuclear and (C) polymorphonuclear cells in the peripheral blood of OVA-
sensitized and challenged female rats. Basal group: naïve animals that remained
undisturbed, with no treatment; Control/OVA: rats prenatally exposed to 0.9% NaCl
solution and OVA-sensitized on PND 60; LPS/OVA: rats prenatally exposed to LPS
and OVA-sensitized on PND 60. All measures were performed 12 h after the OVA
challenge. Values are presented as mean±SEM. n=10 for both groups. Different
superscripts letters mean statistically signiﬁcant differences and the same letters
mean no signiﬁcant differences. ** pb0.01, *** pb0.001 and **** pb0.0001 (ANOVA
and Tukey–Kramer tests).
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group presented a smaller number of cells in the blood than that
measured in both basal (pb0.001) and LPS/OVA (pb0.001) groups; no
differences were detected between basal and LPS/OVA groups (pN0.05).
Regarding the mononuclear cells (Panel B) there was a decrease in the
control/OVA group as compared to the basal group (pb0.001); the LPS/
OVAgrouppresented a signiﬁcant increase in relation to the control/OVA
group (pb0.01) but not in relation to the basal group (pN0.05).
Concerning the circulating polymorphonuclear cells (Panel C) there
was a decrease in the control/OVA group in relation to those of the basal
group (pb0.01); a signiﬁcant increase was found in the LPS/OVA group
compared to the both control group/OVA (pb0.0001) and basal group
(pb0.0001).
No signiﬁcant differenceswere observedbetweengroupswith regard
to the bone marrow analysis (basal group: 40.20±3.80; control/OVA
group: 44.70±3.60; LPS/OVA group: 51.20±3.20; pN0.05).
PCA levels in naïve rats that received serum from OVA-sensitized
female pups (prenatally treated with LPS or vehicle on GD9.5) wereidentical in both groups (basal group: 12.80±1.96; control/OVA
group: 12.80±1.96; LPS/OVA group: 12.80±1.96; pN0.05).
Discussion
The increased levels of total and differential cells located in lung
(BAL) in the control/OVAgroupversus basal group indicate that the lung
allergic response was correctly induced in the rats. Moreover, female
rats prenatally treated with LPS and challenged with OVA as compared
to the control/OVA group presented a lower increase in total and
differential cells located in lung. Thus, prenatal LPS prevented cell
migration to the lung during the allergen response. Furthermore, in the
control/OVA group as compared to the basal group, the number of total,
mononuclear and polymorphonuclear cells in the peripheral blood was
decreased. This decrease is considered normal and occurs due to cellular
migration to the lungs (Ligeiro de Oliveira et al., 2008). However,
females prenatally treated with LPS did not present a decrease in these
parameters, suggesting that peripheral immune cells did not migrate to
lung, probably due to mobilization impairment. Notably, the mobiliza-
tion, activation and trafﬁcking of effector cells to the airway are
controlled by a complex pleiotropic cytokine milieu derived from
resident airway cells including epithelial and airway smooth muscle
cells (Chung, 2001). It has been shown that several substances induce
pro-inﬂammatory cytokines production. In this context, LPS exposure
increases pro-inﬂammatory cytokine levels, such as tumor necrosis
factor-α, interleukin-1, and interleukin-6 in the airway (Oyoshi et al.,
2007). Thus, LPS might have been responsible for that mobilization
impairment.
With regard to bone marrow cellularity, no differences were
observed in rats prenatally treated with LPS, then sensitized and
challenged with OVA in adulthood, as compared to the control/OVA
group. Thus, hematopoiesis (processing, maturation and lymphocyte
differentiation) seems not modiﬁed by prenatal LPS treatment on GD
9.5. However, it should not be forgotten that the quantiﬁcation of the
total cell number in the bone marrow does not exclude possible
alterations on cell maturation or differentiation phases, or on cell
functional or morphological modiﬁcations. These are facts that are
now under investigation.
Moreover, the lack of differences between the groups in the PCA
analysis suggests that a mechanism other than the production of
antibodies was responsible for the LPS-mediated long-term improve-
ment of OVA sensitization effects in rats. To further characterize the
allergic response, we measured the OVA-speciﬁc IgE using PCA as an
index. Signiﬁcant differences were not observed for the levels of OVA-
speciﬁc IgE in the LPS group when compared to the control group.
Besides the previous ﬁndings of our group related to behavioral
impairments (play behavior and adulthood social interaction) in rat
pups prenatally treated with LPS (100 μg/kg on GD 9.5) (Kirsten et al.,
2010b), the present study revealed changes in the immune system
status of these pups. Speciﬁcally, prenatally LPS-treated females
presented during adulthoodwith attenuated experimental lung allergic
response, i.e., reduced lung inﬂammation, a common symptom of
asthma (Bryce et al., 2006; Busse and Lemanske, 2001).
It is felt that the mechanisms responsible for the impairments
presently found and reported in the prenatally LPS-treated female rat
pups do not directly involve LPS; this endotoxinwas not found in pups
after a prenatal injection (Ashdown et al., 2006). It has been suggested
that the effects of maternal LPS exposure on the developing fetus are
mediated by cytokine induction within the maternal circulation and
placenta (Ashdown et al., 2006; Cai et al., 2000; Smith et al., 2007;
Urakubo et al., 2001).
The possibility of using bacterial compounds during gestation in
order to prevent allergic diseases has been studied for some time.
Prenatal LPS (aerosolized) exposure has been shown to prevent
subsequent allergen sensitization in offspring through inhibition of
T-helper type (Th)2 immune responses (Gerhold et al., 2006).However,
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GD 7 until delivery) and the effects were only found when prenatal
treatment was combined with further postnatal LPS exposure (Gerhold
et al., 2006). The present study revealed similar results, butwith a single
exposure to LPS on GD9.5 andwithout postnatal LPS exposure. This fact
strongly reinforces the relevance of an inﬂammatory insult on the
plasticity of lung allergy during the prenatal period.
Similarly, Blumer et al. (2005) found that a subchronic exposure to
LPS (femaleBALB/cmice received three injectionsof LPS ondays5, 3 and
1 prior to mating and during every third day during the gestation
period) modulate the development of allergies in the offspring.
The reason why rats prenatally treated with LPS presented
attenuated cell migration to lungs could be explained by the ‘hygiene
hypothesis’. Shifts in the Th1/Th2 immune system balance seem to ﬁt
well with the so-called ‘hygiene hypothesis’. Normally, the immune
system of animals with allergic diseases such as asthma is inclined
towards Th2-type responses. It is known that animals prenatally
treated with LPS present high levels of pro-inﬂammatory cytokines,
i.e., increased Th1 response (Pavlov and Tracey, 2004). Therefore, the
activation of innate immunity is expected to normalize the Th1 and
Th2 immune system balance and to suppress the excessive reaction of
Th2-type responses (Yoshida et al., 2009).
Incidentally, we speculate that the prenatal LPS treatment on GD 9.5
employed here was effective in suppressing allergen-induced immune
airway responses, interfering with the trafﬁc and/or recruitment of Th2
cells to the sites of inﬂammation.
Conclusion
Although the results indicate a beneﬁcial effect for prenatal LPS
treatment, since female rats presented an attenuated allergic reaction,
studies in other ﬁelds are needed to validate this treatment as a
prophylactic approach to asthma. In fact, rats subjected to this treatment
also presented several behavioral impairments (Kirsten et al., 2010a;
Kirsten et al., 2010b). However, immunomodulation with bacterial
compounds during the gestation period has also been suggested as a
possible effective mode for ﬁrst-step primary prevention of allergic
diseases. Furthermore, the optimal time frames for initiating immuno-
modulation to elicit a sufﬁcient effect against allergen sensitization are
still unclear. These ﬁndings may contribute to understanding the
genesis and treatment of allergic responses, such as asthma. Bacterial
exposure on GD 9.5 in ratsmay be considered for studies of strategies to
prevent the development of allergic diseases.
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